Estradiol valerate improves endometrial receptivity induced by clomiphene in rat with polycystic ovary syndrome
SHAO Rui-feng, HE Chi-hua, WANG Ying
Related Articles |
Objective To investigate the effect of estradiol valerate (E2V) on endometrial receptivity induced by clomiphene in polycystic ovary syndrome (PCOS) rats. Methods Rats were divided into control group (administered 0.9% sodium chloride solution), and PCOS model group (administered 50 mg/kg clomiphene), E2V low, medium and high-dose intervention group [administered (0.2, 0.5, 1.0)mg/kg E2V+50 mg/kg clomiphene]. Serum sex hormone level was compared. Morphological change of endometrium was examined by ELISA. The expression of estrogen receptor (ER), progesterone receptor (PR), homeobox gene (Hox)A10, empty ventilator homeobox (Emx)2, integrin αvβ3 mRNA and protein in the endometrium were detected by real-time fluorescence quantitative polymerase chain reaction (RT-qPCR) and Western blot. Results Compared with the control group, luteinizing hormone/follicle-forming hormone (LH/FSH), testosterone (T), relative expressions of Emx2 mRNA and protein were significantly increased (P＜0.05), while estradiol (E2) level, glandular area, glandular area, endometrial thickness and glandular/interstitial area ratio, relative expressions of ER, PR, HoxA10, integrin αvβ3 mRNA and protein were significantly decreased (P＜0.05). Compared with PCOS model group, the changes of above indexes in E2V low, medium and high-dose intervention group were opposite (P＜0.05). Conclusions E2V can improve endometrial receptivity of PCOS clomiphene-induced ovulation rats. E2V is potentially related to the up-regulation of ER, PR, HoxA10, integrinαvβ3 and down-regulation of Emx2.